...
首页> 外文期刊>Metabolism: Clinical and Experimental >Fibroblast growth factor 21 in cardio-metabolic disorders: a systematic review and meta-analysis
【24h】

Fibroblast growth factor 21 in cardio-metabolic disorders: a systematic review and meta-analysis

机译:心肌代谢障碍的成纤维细胞生长因子21:系统评价和荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Fibroblast growth factor 21 is a signalling protein involved in cell differentiation, morphogenesis, proliferation and metabolism. Recent studies have associated increased levels of FGF21 in the development of cardiovascular diseases, whereas others have reported no significant associations. Therefore, this systematic review and meta-analysis evaluated the value in predicting the risk of cardio-metabolic disorders and mortality.
机译:背景:成纤维细胞生长因子21是参与细胞分化,形态发生,增殖和代谢的信号蛋白。 最近的研究在心血管疾病发展中有相关的FGF21水平,而其他研究则报告没有重大协会。 因此,这种系统审查和荟萃分析评估了预测心肌代谢障碍和死亡率风险的价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号